Search Results - "Maffei, Francisco H. A."

Plasma kallikrein enhances platelet aggregation response by subthreshold doses of ADP by Ottaiano, Tatiana F., Andrade, Sheila S., de Oliveira, Cleide, Silva, Mariana C.C., Buri, Marcus V., Juliano, Maria A., Girão, Manoel J.B.C., Sampaio, Misako U., Schmaier, Alvin H., Wlodawer, Alexander, Maffei, Francisco H.A., Oliva, Maria Luiza V.

“…Human plasma kallikrein (huPK) potentiates platelet responses to subthreshold doses of ADP, although huPK itself, does not induce platelet aggregation. In the…”
Get full text

Highlights from the I international symposium of thrombosis and anticoagulation in internal medicine, October 23–25, 2008, Sao Paulo, Brazil by Lopes, Renato D., Becker, Richard C., Garcia, David, Hylek, Elaine M., Granger, Christopher B., Lourenço, Dayse M., Nader, Helena B., Maffei, Francisco H. A., Cesena, Fernando H. Y., Nicolau, José C., Timmerman, Ari, Rocha, Ana T., de Paiva, Edison F., Guimaraes, Helio P., Carvalho, Antonio C., D’Amico, Elbio A., Moreira-Filho, Carlos A., Aldrighi, José M., Lopes, Antonio C.

“…The importance of thrombosis and anticoagulation in clinical practice is rooted firmly in several fundamental constructs that can be applied both broadly and…”
Get full text

Prophylaxis of deep-vein thrombosis after lower extremity amputation: comparison of low molecular weight heparin with unfractionated heparin by Lastória, Sidney, Rollo, Hamilton A, Yoshida, Winston Bonetti, Giannini, Mariangela, Moura, Regina, Maffei, Francisco H A

“…To compare the efficacy and safety of a low molecular weight heparin (enoxaparin) with unfractionated heparin (UH) in this prophylaxis. Seventy five patients…”
Get full text

The Kallikrein Inhibitor from Bauhinia bauhinioides (BbKI) shows antithrombotic properties in venous and arterial thrombosis models by Brito, Marlon V, de Oliveira, Cleide, Salu, Bruno R, Andrade, Sonia A, Malloy, Paula M.D, Sato, Ana C, Vicente, Cristina P, Sampaio, Misako U, Maffei, Francisco H.A, Oliva, Maria Luiza V

“…Abstract The Bauhinia bauhinioides Kallikrein Inhibitor (BbKI) is a Kunitz-type serine peptidase inhibitor of plant origin that has been shown to impair the…”
Get full text

An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis by Ramacciotti, Eduardo, Araújo, Gilson R., Lastoria, Sidnei, Maffei, Francisco H.A., Karaoglan de Moura, Liberato, Michaelis, Wilson, Sandri, João Luis, Dietrich-Neto, Flávia

“…Background: Treatment of deep-vein thrombosis (DVT) with a once-daily regimen of enoxaparin, rather than a continuous infusion of unfractionated heparin (UFH)…”
Get full text

Combinations of low doses of unfractionated heparin and of low-molecular-weight heparin prevent experimental venous thrombosis by Carelli, Guareide, Maffei, Francisco H A, Mattar, Luci, Ferrari, Iracema C, Thomazini-Santos, Izolete A, de Carvalho, Lídia R

“…Synergism between low-molecular-weight heparin and low doses of unfractionated heparin (UH) enhancing anti-factor Xa activity and the release of tissue factor…”
Get more information